Guggenheim Capital LLC Atri Cure, Inc. Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $407,020 - $496,202	-5,875 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$64.13 - $80.18 $68,747 - $85,952	-1,072 Reduced 15.43%	5,875 $466,000
Q1 2021 May 13, 2021	SELL	$53.79 - $66.98 $5,594 - $6,965	-104 Reduced 1.47%	6,947 $455,000
Q4 2020 Feb 16, 2021	SELL	$34.56 - $57.55 $4,596 - $7,654	-133 Reduced 1.85%	7,051 $393,000
Q3 2020 Nov 13, 2020	SELL	$38.36 - $46.91 $7,710 - $9,428	-201 Reduced 2.72%	7,184 $287,000
Q2 2020 Aug 14, 2020	SELL	$31.78 - $51.19 $6,387 - $10,289	-201 Reduced 2.65%	7,385 $332,000
Q1 2020 Jun 02, 2020	BUY	$24.49 - $43.84 $342 - $613	14 Added 0.18%	7,586 $255,000
Q4 2019 Feb 14, 2020	BUY	$24.06 - $32.51 $182,182 - $246,165	7,572 New	7,572 $246,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.63B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.